IDEAYA Biosciences, Inc. (IDYA)

Last Closing Price: 21.64 (2025-06-03)

Company Description

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $7.00M
Net Income (Most Recent Fiscal Year) $-274.48M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.81
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -4386.90%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -29.28%
Return on Assets (Trailing 12 Months) -27.68%
Current Ratio (Most Recent Fiscal Quarter) 13.92
Quick Ratio (Most Recent Fiscal Quarter) 13.92
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $12.25
Earnings per Share (Most Recent Fiscal Quarter) $-0.82
Earnings per Share (Most Recent Fiscal Year) $-3.36
Diluted Earnings per Share (Trailing 12 Months) $-3.59
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 87.58M
Free Float 85.39M
Market Capitalization $1.86B
Average Volume (Last 20 Days) 1.40M
Beta (Past 60 Months) 0.04
Percentage Held By Insiders (Latest Annual Proxy Report) 2.50%
Percentage Held By Institutions (Latest 13F Reports) 98.29%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%